RISING

📅 Upcoming

🕒 Recent(90d)

News

• AbbVie touts strong momentum for Skyrizi despite rising competition
  If AbbVie executives are bothered by growing threats to their immunology powerhouse, they aren't letting on. Earlier this year, analysts were pondering how the company’s blockbuster Skyrizi might f…
  endpoints · 4h ago
• STAT+: Trump administration revises rebate pilot for 340B drug discount program, angering hospitals
  The Trump administration is revising its rebate pilot for the 340B drug discount program, angering hospitals.
  stat · 5h ago
• STAT+: Up and down the ladder: The latest comings and goings
  From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
  stat · 8h ago
• STAT+: Pharmalittle: We’re reading about a Novo setback, support for Replimune’s melanoma drug, and more
  An FDA advisory panel recommended use of an experimental Replimune treatment for advanced melanoma that the agency has rejected twice
  stat · 9h ago
• Syphilis spreads while researchers contend with federal constraints and a drug shortage
  At the San Diego-Tijuana border, syphilis spreads while researchers contend with federal constraints and a drug shortage.
  stat · 14h ago
• Judge denies states’ motion to postpone Medicaid work requirement
  Federal judge denied 26 states’ request to postpone the implementation of Medicaid work requirements announced in June.
  stat · 1d ago
• STAT+: Rising oil prices can boost the cost of some medicines. One expert says it’s time to lower reliance on fossil fuels
  Unitaid found the rising price of oil could boost the cost of a widely used HIV medicine it reviewed in a detailed analysis.
  stat · 1d ago
• Ebola outbreak nears milestone, while a vaccine remains months away
  Medicaid work rules, FTC sues Hims, and more health news from Morning Rounds
  stat · 1d ago
• NSF testing new Ph.D. model giving trainees academic and industry experience
  Students working in fields eligible for NSF funding will be able to participate, including chemistry, engineering, and basic life science research that doesn’t deal directly with the treatment of d…
  stat · 2d ago
• STAT+: Hims misled consumers and violated their privacy, FTC alleges in a lawsuit
  The U.S. Federal Trade Commission sued telehealth company Hims & Hers alleging business practices that agency says misled consumers.
  stat · 2d ago